Tuesday October 17th 2017

[Comment] New treatments for multiple sclerosis: at what long-term risk?

Since 1993, eight different classes of disease-modifying therapies for relapsing-remitting multiple sclerosis (MS) have been developed and released to market. These drugs, to varying degrees, reduced the frequency of MS relapses, the accumulation of lesions on MRI, and the progression of disability in randomised controlled trials with follow-up of 2–3 years. The first generation of treatments, beta interferons and glatiramer acetate, also delay a second relapse and thus the risk of conversion to clinically definite MS in patients with a first clinical demyelinating event. (Source: Lancet Neurology)

Continue reading:  

[Comment] New treatments for multiple sclerosis: at what long-term risk?

Leave a Comment

More from category

Roche to present new OCREVUS (ocrelizumab) efficacy and safety data in relapsing and primary progressive forms of multiple sclerosis at ECTRIMS
Roche to present new OCREVUS (ocrelizumab) efficacy and safety data in relapsing and primary progressive forms of multiple sclerosis at ECTRIMS

Roche announced today that new data on OCREVUS ® (ocrelizumab) in people with relapsing and primary progressive forms [Read More]

All you need to know about dysesthesia
All you need to know about dysesthesia

Dysesthesia is a painful, itchy sensation, often associated with multiple sclerosis (MS). Learn more about the symptoms [Read More]

Medical News Today: All you need to know about dysesthesia
Medical News Today: All you need to know about dysesthesia

Dysesthesia is a painful, itchy sensation, often associated with multiple sclerosis (MS). Learn more about the symptoms [Read More]

MRI brain scans can reveal MS risk in children before clinical symptoms appear
MRI brain scans can reveal MS risk in children before clinical symptoms appear

By the time multiple sclerosis (MS) is diagnosed in children, it may be difficult to prevent the disabilities and [Read More]

Open Enrollment for Marketplace and Medicare Plans
Open Enrollment for Marketplace and Medicare Plans

/About-the-Society/News/Open-Enrollment-for-Marketplace-and-Medicare-Plans [Read More]